54.73
price down icon5.16%   -2.98
after-market After Hours: 54.68 -0.05 -0.09%
loading
Bio Techne Corp stock is traded at $54.73, with a volume of 2.88M. It is down -5.16% in the last 24 hours and up +6.38% over the past month. Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
See More
Previous Close:
$57.71
Open:
$56.73
24h Volume:
2.88M
Relative Volume:
1.25
Market Cap:
$8.58B
Revenue:
$1.17B
Net Income/Loss:
$150.71M
P/E Ratio:
58.22
EPS:
0.94
Net Cash Flow:
$245.03M
1W Performance:
-6.40%
1M Performance:
+6.38%
6M Performance:
-25.59%
1Y Performance:
-32.92%
1-Day Range:
Value
$54.61
$57.74
1-Week Range:
Value
$54.61
$60.05
52-Week Range:
Value
$46.01
$83.33

Bio Techne Corp Stock (TECH) Company Profile

Name
Name
Bio Techne Corp
Name
Phone
(612) 379-8854
Name
Address
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Name
Employee
3,100
Name
Twitter
@biotechne
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
TECH's Discussions on Twitter

Compare TECH with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TECH
Bio Techne Corp
54.73 9.05B 1.17B 150.71M 245.03M 0.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.87 120.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.46 59.88B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
392.24 44.31B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
670.33 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
301.13 32.46B 3.81B -644.79M -669.77M -6.24

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-22-25 Resumed Stephens Overweight
Jul-09-25 Initiated TD Cowen Buy
May-30-25 Initiated Wells Fargo Overweight
Apr-09-25 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Mar-18-25 Initiated Evercore ISI Outperform
Feb-19-25 Downgrade Robert W. Baird Outperform → Neutral
May-22-24 Downgrade Citigroup Buy → Neutral
Feb-08-24 Initiated Scotiabank Sector Outperform
Feb-02-24 Downgrade Stifel Buy → Hold
Dec-07-23 Initiated UBS Buy
Aug-28-23 Initiated William Blair Outperform
Jan-10-23 Upgrade Wells Fargo Underweight → Equal Weight
Dec-14-22 Initiated Deutsche Bank Buy
Dec-12-22 Upgrade Citigroup Neutral → Buy
Dec-07-22 Initiated RBC Capital Mkts Sector Perform
Aug-25-22 Initiated Credit Suisse Outperform
Apr-25-22 Downgrade Wells Fargo Equal Weight → Underweight
Sep-15-21 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-08-21 Upgrade Stephens Equal-Weight → Overweight
Feb-23-21 Upgrade Stifel Hold → Buy
Jan-25-21 Reiterated The Benchmark Company Buy
Nov-10-20 Initiated KeyBanc Capital Markets Sector Weight
Sep-30-20 Initiated Atlantic Equities Overweight
Jul-15-20 Downgrade Stephens Overweight → Equal-Weight
May-27-20 Downgrade Stifel Buy → Hold
May-14-20 Initiated The Benchmark Company Buy
Jan-08-20 Resumed Stephens Overweight
Jan-08-20 Initiated Wells Fargo Equal Weight
Jan-07-20 Initiated Citigroup Neutral
Nov-15-19 Initiated Stifel Buy
Jul-02-19 Upgrade Janney Neutral → Buy
Jan-14-19 Upgrade Stephens Equal-Weight → Overweight
Oct-31-18 Downgrade Craig Hallum Buy → Hold
Oct-17-18 Initiated Goldman Neutral
Jun-15-18 Initiated Argus Buy
Jul-13-17 Initiated Wells Fargo Market Perform
Feb-09-17 Initiated Citigroup Buy
Jan-18-17 Initiated Deutsche Bank Buy
Nov-10-16 Resumed Leerink Partners Outperform
Jan-21-15 Reiterated Robert W. Baird Outperform
Sep-20-13 Upgrade Robert W. Baird Neutral → Outperform
View All

Bio Techne Corp Stock (TECH) Latest News

pulisher
Jul 30, 2025

Promising Long-Term Growth for Bio-Techne Amidst Current Challenges: A Buy Recommendation by Kyle Boucher - TipRanks

Jul 30, 2025
pulisher
Jul 29, 2025

Will Bio Techne Corporation stock benefit from interest rate changesProfit Target Stock Opportunity Monitor Activated - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Momentum Screeners Rank Bio Techne Corporation in Top 5 TodayReal-Time Trade Insights Spark Market Reactions - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate Bio Techne Corporation as a “Buy”Discover the fastest growing stocks today - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

When is Bio Techne Corporation stock expected to show significant growthUnlock real-time stock alerts for quick profits - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How strong is Bio Techne Corporation company’s balance sheetSuperior profit margins - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Bio-Techne Corporation (TECH) Gets Initiated With a New Buy Rating at TD Cowen - Insider Monkey

Jul 28, 2025
pulisher
Jul 28, 2025

What makes Bio Techne Corporation stock price move sharplyAchieve rapid capital gains with smart investing - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Is Bio Techne Corporation stock overvalued or undervaluedDiscover stocks with explosive upside potential - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Estimating The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH) - Yahoo Finance

Jul 27, 2025
pulisher
Jul 26, 2025

Bio-Techne’s Quarterly Earnings Preview: What You Need to Know - MSN

Jul 26, 2025
pulisher
Jul 25, 2025

10 Most Profitable Biotech Stocks to Invest in Now - Insider Monkey

Jul 25, 2025
pulisher
Jul 24, 2025

Bio-Techne Corporation (TECH): A Bull Case Theory - Yahoo Finance

Jul 24, 2025
pulisher
Jul 22, 2025

What analysts say about Bio Techne Corporation stockTriple returns potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Bio-Techne (TECH) Stock Is Up, What You Need To Know - Yahoo Finance

Jul 22, 2025
pulisher
Jul 22, 2025

Bio Techne Corporation Stock Analysis and ForecastFree Investment Community - Autocar Professional

Jul 22, 2025
pulisher
Jul 21, 2025

Bio-Techne Corporation shares rise 1.99% after-hours as US stocks close higher. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Bio-Techne Corp. stock underperforms Monday when compared to competitors - MarketWatch

Jul 21, 2025
pulisher
Jul 18, 2025

Envestnet Asset Management Inc. Sells 66,478 Shares of Bio-Techne Corp (NASDAQ:TECH) - Defense World

Jul 18, 2025
pulisher
Jul 18, 2025

Bio-Techne’s Quarterly Earnings Preview: What You Need To Know - Barchart.com

Jul 18, 2025
pulisher
Jul 17, 2025

Bio-Techne Schedules Q4 2025 Earnings Call: Full Fiscal Year Results Coming August 6 - Stock Titan

Jul 17, 2025
pulisher
Jul 16, 2025

Bio-Techne to distribute Spear Bio’s ultrasensitive immunoassays - Yahoo Finance

Jul 16, 2025
pulisher
Jul 16, 2025

Bio-Techne Corp (NASDAQ:TECH) Stake Lessened by M&T Bank Corp - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

Analysts Set Bio-Techne Corp (NASDAQ:TECH) Price Target at $70.00 - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

Why Bio Techne Corporation stock attracts strong analyst attentionProfitable Yet Secure Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Bio Techne Corporation stock performs during market volatilityFree Expert-Led Investment Training - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Here’s Headwaters Capital Management’s Investment Thesis for Bio-Techne (TECH) - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

Spear Bio partners with Bio-Techne to expand ultrasensitive assay access By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Spear Bio partners with Bio-Techne to expand ultrasensitive assay access - Investing.com

Jul 15, 2025
pulisher
Jul 15, 2025

Bio-Techne Secures 1000x More Sensitive Biomarker Detection Technology in Major Neuroscience Partnership - Stock Titan

Jul 15, 2025
pulisher
Jul 15, 2025

Bio-Techne (TECH) Partners with Spear Bio for Advanced Biomarker Detection | TECH Stock News - GuruFocus

Jul 15, 2025
pulisher
Jul 15, 2025

Revolutionary Alzheimer's Biomarker Detection: Bio-Techne's New Platform Achieves 1000x Higher Sensitivity - Stock Titan

Jul 15, 2025
pulisher
Jul 14, 2025

Bio-techne’s technology supports FDA approval of rare skin disorder therapy - Investing.com

Jul 14, 2025
pulisher
Jul 14, 2025

Bio-Techne's Simple Western Enables Breakthrough FDA Approval for Rare Skin Disease Gene Therapy - Stock Titan

Jul 14, 2025
pulisher
Jul 13, 2025

Teacher Retirement System of Texas Makes New Investment in Bio-Techne Corp (NASDAQ:TECH) - Defense World

Jul 13, 2025
pulisher
Jul 13, 2025

Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Principal Financial Group Inc. - Defense World

Jul 13, 2025
pulisher
Jul 13, 2025

Teacher Retirement System of Texas Acquires New Holdings in Bio-Techne Corp (NASDAQ:TECH) - Defense World

Jul 13, 2025
pulisher
Jul 13, 2025

Scotiabank Has Lowered Expectations for Bio-Techne (NASDAQ:TECH) Stock Price - Defense World

Jul 13, 2025
pulisher
Jul 12, 2025

Scotiabank Maintains Buy Rating for Bio-Techne with $75 Price Target - AInvest

Jul 12, 2025
pulisher
Jul 11, 2025

Bio-Techne stock price target lowered to $75 by Scotiabank - Investing.com Canada

Jul 11, 2025
pulisher
Jul 11, 2025

TD Cowen Begins Coverage on Bio-Techne (NASDAQ:TECH) - Defense World

Jul 11, 2025
pulisher
Jul 10, 2025

Minnesota's highest-paid CEOs made 7% more, with highest paid making $59.4M - Star Tribune

Jul 10, 2025
pulisher
Jul 09, 2025

Assessing Bio-Techne: Insights From 7 Financial Analysts - Benzinga

Jul 09, 2025
pulisher
Jul 09, 2025

Bio-Techne (TECH) Receives Buy Rating with $65 Price Target from TD Cowen | TECH Stock News - GuruFocus

Jul 09, 2025
pulisher
Jul 09, 2025

Bio-Techne (TECH): TD Cowen Initiates Coverage with Buy Rating | - GuruFocus

Jul 09, 2025
pulisher
Jul 09, 2025

Vontobel Holding Ltd. Decreases Stake in Bio-Techne Corp (NASDAQ:TECH) - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

5 Revealing Analyst Questions From Bio-Techne’s Q1 Earnings Call - Yahoo Finance

Jul 09, 2025
pulisher
Jul 08, 2025

Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch

Jul 08, 2025
pulisher
Jul 07, 2025

GAMMA Investing LLC Cuts Stake in Bio-Techne Corp (NASDAQ:TECH) - Defense World

Jul 07, 2025
pulisher
Jul 07, 2025

Amalgamated Bank Purchases 222 Shares of Bio-Techne Corp (NASDAQ:TECH) - Defense World

Jul 07, 2025
pulisher
Jul 06, 2025

Is There Now An Opportunity In Bio-Techne Corporation (NASDAQ:TECH)? - Yahoo Finance

Jul 06, 2025

Bio Techne Corp Stock (TECH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$74.89
price down icon 3.43%
$36.80
price down icon 0.86%
$107.28
price up icon 2.00%
$26.37
price down icon 1.09%
$107.50
price down icon 2.32%
biotechnology ONC
$301.13
price up icon 0.40%
Cap:     |  Volume (24h):